• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Catalog Number 600112480
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Bradycardia (1751); Heart Block (4444)
Event Date 07/08/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Clinical information: crd_992 - valved grafts pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 27mm sjm masters series valsalva aortic valved graft was chosen for implant.The graft was successfully placed without difficulty.Post implant, the myocardial pacing leads were left in place per usual.On (b)(6) 2023, atrial fibrillation with bradycardia and atrioventricular block were detected via electrocardiogram (ecg).Amiodarone was administered as treatment.Another ecg was taken on (b)(6) 2023, and it was confirmed that the patient was in sinus rhythm.On (b)(6) 2023, the myocardial pacing leads were removed.A transthoracic echocardiogram (tte) was performed on 17 july, which showed a single pericardial effusion in the right ventricle with 17mm in the right anterior ventricle, 17mm next to the pulmonary infundibulum, and 5-6mm in the right inferior ventricle.Another tte was taken on (b)(6) 2023, and the pericardial effusion was the same size (18mm maximum) and was stable.No intervention was provided to treat the pericardial effusion.It was stated that the pericardial effusion was caused by the removal of the myocardial leads.The patient was discharged the following day on (b)(6) 2023.
 
Manufacturer Narrative
An event of arrhythmia two days after the masters grafted valve was implanted and pericardial effusion caused by the removal of the myocardial leads was reported.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that arrhythmia was not related to valve malfunction.The root cause of the reported event could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17455008
MDR Text Key320374116
Report Number2135147-2023-03399
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734009515
UDI-Public05414734009515
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2023
Device Catalogue Number600112480
Device Lot Number8064294
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
Patient SexMale
Patient Weight96 KG
-
-